Identification of Flucloxacillin-Haptenated HLA-B*57:01 Ligands: Evidence of Antigen Processing and Presentation



Waddington, James C, Meng, Xiaoli ORCID: 0000-0002-7774-2075, Illing, Patricia T, Tailor, Arun, Adair, Kareena ORCID: 0000-0001-9884-2094, Whitaker, Paul, Hamlett, Jane, Jenkins, Rosalind E, Farrell, John ORCID: 0000-0002-8726-5997, Berry, Neil ORCID: 0000-0003-1928-0738
et al (show 3 more authors) (2020) Identification of Flucloxacillin-Haptenated HLA-B*57:01 Ligands: Evidence of Antigen Processing and Presentation TOXICOLOGICAL SCIENCES, 177 (2). pp. 454-465. ISSN 1096-6080, 1096-0929

[thumbnail of Final_Manuscript_Waddington_TS_Clear.docx] Text
Final_Manuscript_Waddington_TS_Clear.docx - Author Accepted Manuscript

Download (148kB)

Abstract

Flucloxacillin is a b-lactam antibiotic associated with a high incidence of drug-induced liver reactions. Although expression of human leukocyte antigen (HLA)-B∗57:01 increases susceptibility, little is known of the pathological mechanisms involved in the induction of the clinical phenotype. Irreversible protein modification is suspected to drive the reaction through the modification of peptides that are presented by the risk allele. In this study, the binding of flucloxacillin to immune cells was characterized and the nature of the peptides presented by HLA-B∗57:01 was analyzed using mass spectrometric-based immunopeptidomics methods. Flucloxacillin modification of multiple proteins was observed, providing a potential source of neoantigens for HLA presentation. Of the peptides eluted from flucloxacillin-treated C1R-B∗57:01 cells, 6 putative peptides were annotated as flucloxacillin-modified HLA-B∗57:01 peptide ligands (data are available via ProteomeXchange with identifier PXD020137). To conclude, we have characterized naturally processed drug-haptenated HLA ligands presented on the surface of antigen presenting cells that may drive drug-specific CD8 T-cell responses.

Item Type: Article
Uncontrolled Keywords: haptenated HLA ligands, immune-mediated liver injury, intracellular covalent binding
Depositing User: Symplectic Admin
Date Deposited: 14 Aug 2020 09:29
Last Modified: 16 Jun 2026 07:20
DOI: 10.1093/toxsci/kfaa124
Related Websites:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3097523
Disclaimer: The University of Liverpool is not responsible for content contained on other websites from links within repository metadata. Please contact us if you notice anything that appears incorrect or inappropriate.